vs

Side-by-side financial comparison of WM TECHNOLOGY, INC. (MAPS) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $43.1M, roughly 1.0× WM TECHNOLOGY, INC.). WM TECHNOLOGY, INC. runs the higher net margin — -8.3% vs -90.4%, a 82.1% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -9.7%). WM TECHNOLOGY, INC. produced more free cash flow last quarter ($-280.0K vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -1.5%).

WM Entertainment is a South Korean entertainment company established in 2008 by former singer Lee Won-min. The company is responsible for managing artist Oh My Girl. On April 7, 2021, the company was acquired by RBW.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

MAPS vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.0× larger
PACB
$44.6M
$43.1M
MAPS
Growing faster (revenue YoY)
PACB
PACB
+23.5% gap
PACB
13.8%
-9.7%
MAPS
Higher net margin
MAPS
MAPS
82.1% more per $
MAPS
-8.3%
-90.4%
PACB
More free cash flow
MAPS
MAPS
$19.6M more FCF
MAPS
$-280.0K
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-1.5%
MAPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MAPS
MAPS
PACB
PACB
Revenue
$43.1M
$44.6M
Net Profit
$-3.6M
$-40.4M
Gross Margin
94.9%
37.1%
Operating Margin
-13.5%
-92.3%
Net Margin
-8.3%
-90.4%
Revenue YoY
-9.7%
13.8%
Net Profit YoY
-251.9%
-1802.7%
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MAPS
MAPS
PACB
PACB
Q4 25
$43.1M
$44.6M
Q3 25
$42.2M
$38.4M
Q2 25
$44.8M
$39.8M
Q1 25
$44.6M
$37.2M
Q4 24
$47.7M
$39.2M
Q3 24
$46.6M
$40.0M
Q2 24
$45.9M
$36.0M
Q1 24
$44.4M
$38.8M
Net Profit
MAPS
MAPS
PACB
PACB
Q4 25
$-3.6M
$-40.4M
Q3 25
$2.5M
$-38.0M
Q2 25
$1.4M
$-41.9M
Q1 25
$1.6M
$-426.1M
Q4 24
$2.4M
$2.4M
Q3 24
$3.3M
$-60.7M
Q2 24
$716.0K
$-173.3M
Q1 24
$1.2M
$-78.2M
Gross Margin
MAPS
MAPS
PACB
PACB
Q4 25
94.9%
37.1%
Q3 25
95.0%
41.4%
Q2 25
94.9%
36.9%
Q1 25
95.0%
-3.7%
Q4 24
95.2%
25.6%
Q3 24
95.3%
25.0%
Q2 24
95.1%
16.5%
Q1 24
94.8%
29.1%
Operating Margin
MAPS
MAPS
PACB
PACB
Q4 25
-13.5%
-92.3%
Q3 25
4.6%
-101.1%
Q2 25
4.4%
-112.8%
Q1 25
5.9%
-1154.5%
Q4 24
9.6%
-390.1%
Q3 24
11.2%
-160.3%
Q2 24
2.7%
-488.3%
Q1 24
8.5%
-209.6%
Net Margin
MAPS
MAPS
PACB
PACB
Q4 25
-8.3%
-90.4%
Q3 25
5.8%
-98.9%
Q2 25
3.2%
-105.4%
Q1 25
3.7%
-1146.8%
Q4 24
4.9%
6.0%
Q3 24
7.2%
-151.9%
Q2 24
1.6%
-481.3%
Q1 24
2.8%
-201.4%
EPS (diluted)
MAPS
MAPS
PACB
PACB
Q4 25
$-0.11
Q3 25
$-0.13
Q2 25
$-0.14
Q1 25
$0.02
$-1.44
Q4 24
$-0.44
Q3 24
$-0.22
Q2 24
$-0.64
Q1 24
$0.01
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MAPS
MAPS
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$62.4M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$57.2M
$5.3M
Total Assets
$190.7M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MAPS
MAPS
PACB
PACB
Q4 25
$62.4M
$279.5M
Q3 25
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
Q4 24
$52.0M
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Stockholders' Equity
MAPS
MAPS
PACB
PACB
Q4 25
$57.2M
$5.3M
Q3 25
$56.9M
$36.1M
Q2 25
$52.7M
$61.5M
Q1 25
$48.5M
$91.6M
Q4 24
$36.1M
$506.6M
Q3 24
$29.5M
$453.1M
Q2 24
$24.5M
$492.7M
Q1 24
$20.8M
$649.0M
Total Assets
MAPS
MAPS
PACB
PACB
Q4 25
$190.7M
$784.1M
Q3 25
$192.9M
$803.2M
Q2 25
$188.1M
$825.5M
Q1 25
$183.8M
$860.8M
Q4 24
$181.9M
$1.3B
Q3 24
$173.6M
$1.5B
Q2 24
$168.0M
$1.5B
Q1 24
$165.8M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MAPS
MAPS
PACB
PACB
Operating Cash FlowLast quarter
$3.0M
$-19.1M
Free Cash FlowOCF − Capex
$-280.0K
$-19.9M
FCF MarginFCF / Revenue
-0.7%
-44.6%
Capex IntensityCapex / Revenue
7.7%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$13.5M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MAPS
MAPS
PACB
PACB
Q4 25
$3.0M
$-19.1M
Q3 25
$6.4M
$-18.7M
Q2 25
$11.1M
$-29.4M
Q1 25
$5.7M
$-44.1M
Q4 24
$9.4M
$-30.6M
Q3 24
$7.2M
$-45.5M
Q2 24
$12.7M
$-54.3M
Q1 24
$7.4M
$-75.7M
Free Cash Flow
MAPS
MAPS
PACB
PACB
Q4 25
$-280.0K
$-19.9M
Q3 25
$3.6M
$-18.8M
Q2 25
$8.2M
$-29.9M
Q1 25
$2.0M
$-45.4M
Q4 24
$7.3M
$-32.3M
Q3 24
$4.9M
$-46.3M
Q2 24
$10.1M
$-55.7M
Q1 24
$2.9M
$-79.6M
FCF Margin
MAPS
MAPS
PACB
PACB
Q4 25
-0.7%
-44.6%
Q3 25
8.4%
-48.9%
Q2 25
18.3%
-75.3%
Q1 25
4.5%
-122.3%
Q4 24
15.2%
-82.3%
Q3 24
10.4%
-115.7%
Q2 24
21.9%
-154.8%
Q1 24
6.4%
-205.0%
Capex Intensity
MAPS
MAPS
PACB
PACB
Q4 25
7.7%
1.9%
Q3 25
6.8%
0.2%
Q2 25
6.3%
1.4%
Q1 25
8.2%
3.7%
Q4 24
4.5%
4.1%
Q3 24
5.1%
2.0%
Q2 24
5.7%
4.1%
Q1 24
10.2%
10.0%
Cash Conversion
MAPS
MAPS
PACB
PACB
Q4 25
Q3 25
2.61×
Q2 25
7.75×
Q1 25
3.44×
Q4 24
4.00×
-12.93×
Q3 24
2.17×
Q2 24
17.67×
Q1 24
5.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MAPS
MAPS

Services$39.5M92%
Other$3.6M8%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons